Ranbaxy Laboratories
BSE: 500359 | NSE: RANBAXY | ISIN: INE015A01028 | Pharmaceuticals
| Finished Products | --------------------------- in Rs. Cr. --------------------------- | Dec 2008 | |||
| Product Name | Unit | Installed Capacity |
Production Quantity |
Sales Quantity |
Sales Value |
| Tablets | Millions Numbers | 9,424 | 5,665.98 | 7,310.66 | 2,062.28 |
| Active Pharma Ingredients | Metric Tonnes | 2,002 | 1,322.57 | 1,531.40 | 1,205.90 |
| Formulation (Capsules) | Millions Numbers | 2,992 | 1,632.25 | 2,022.68 | 606.29 |
| Injectible Vials | Millions Numbers | 39 | 45.75 | 103.30 | 281.05 |
| Syrups & Powders Dry | Millions Bottles | 44 | 32.85 | 50.87 | 266.15 |
| Ointments | - | NA | 497.59 | 1,357.50 | 150.49 |
| Liquids | - | NA | 742.47 | 3,621.52 | 97.05 |
| Other Fiscal Benefits | - | NA | NA | NA | 87.07 |
| Ampoules | Millions Numbers | 48 | 108.11 | 104.59 | 78.84 |
| Other Chemicals | - | NA | NA | NA | 65.08 |
| Sundries | - | NA | NA | NA | 58.45 |
| Royalty Income | - | NA | NA | NA | 18.26 |
| Drops | - | NA | 32.88 | 39.13 | 7.70 |
| Bulk Drugs | - | NA | NA | NA | 0.00 |
| Total | 4,984.61 | ||||
![]() | |||||
| Source : Religare Technova | |||||
![]() | |||||




Online










